Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi
2026 World Cup
Rewards
Home
Price Prediction
TEVA (Teva Pharmaceutical-Sp) Price Prediction
Teva Pharmaceutical-Sp

TEVA(Teva Pharmaceutical-Sp)

$33.46-1.29%

TEVA(Teva Pharmaceutical-Sp) Price Prediction Summary

AI-Generated
As of July 1, 2026, TEVA is currently trading in consolidation with a moderate bullish lean. Technical indicators confirm price above long-term moving averages while the 50-day MA signals caution, and MACD recovery coupled with neutral RSI suggests quiet momentum building. Sentiment is constructively positioned—low IV and strong call dominance, backed by analyst targets near $40.90, paint an optimistic near-term picture. Structurally, 62\% institutional ownership and minimal short float create a favorable long-bias environment. However, uncertainty persists around near-term momentum sustainability; RSI needs to clear 55+ and price must reclaim the MA50 for confirmation. Key thresholds: watch $33.94 \(MA50\) for support and $35–36 as potential resistance. IV rank expansion or put-call compression would signal fading sentiment.
Technical Indicators
Short-Term Bullish

Daily price above key moving averages, though MA50 signals caution; RSI near midpoint reflects consolidation.

Market Sentiment
Moderately Bullish

Low implied volatility and strong call buying favor upside; analyst target suggests further gains ahead.

Market Structure
Institutional Support Strong

Heavy institutional ownership and minimal short interest create a favorable long-biased structure.

Key Trading Levels

How Gate Predicts TEVA(Teva Pharmaceutical-Sp) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of July 1, 2026, **TEVA technical analysis** shows a price positioned above both the 20-day and 200-day moving averages \(SMA20: 33.50, SMA200: 29.32\), supporting a buy bias on the daily timeframe. However, the 50-day MA sits at 33.94, slightly above price, creating a pullback signal that moderates near-term strength. MACD sits at –0.1053 with a buy action, indicating early bullish momentum recovery despite remaining in negative territory. The RSI \(14\) reading of 51.11 sits squarely at neutral midpoint, reflecting neither overbought nor oversold conditions—a consolidation picture. The TEVA price forecast hinges on whether bulls can sustain above the 50-day MA; a break above 33.94 would reaffirm the uptrend, while a close below would invite profit-taking. Watch the MA50/MA20 crossover and RSI movement toward 55–60 as key momentum confirmation signals.
IndicatorValueSignal
Exponential Moving Average (10)33.4273
Buy
Exponential Moving Average (100)32.3674
Buy
Exponential Moving Average (20)33.5308
Sell
Exponential Moving Average (200)29.5132
Buy
Exponential Moving Average (30)33.5735
Sell
Exponential Moving Average (50)33.4099
Buy
Hull Moving Average (9)33.6574
Sell
Ichimoku Base Line (9, 26, 52, 26)33.135
neutral
Moving Averages Summary—
neutral
Simple Moving Average (10)33.113
Buy
Simple Moving Average (100)32.7516
Buy
Simple Moving Average (20)33.483
Sell
Simple Moving Average (200)29.3202
Buy
Simple Moving Average (30)33.767
Sell
Simple Moving Average (50)33.9294
Sell
Volume Weighted Moving Average (20)33.4097
Buy
Average Directional Index (14)10.4702
neutral
Awesome Oscillator-0.2796
neutral
Bull Bear Power0.4433
Buy
Commodity Channel Index (20)11.5954
neutral
MACD Level (12, 26)-0.1316
Buy
Momentum (10)0.53
Buy
Oscillators Summary—
neutral
Relative Strength Index (14)49.1826
neutral
Stochastic %K (14, 3, 3)61.6479
neutral
Stochastic RSI Fast (3, 3, 14, 14)77.7094
neutral
Ultimate Oscillator (7, 14, 28)50.8938
neutral
Williams Percent Range (14)-40.6742
neutral
Technical Summary—
neutral

Market Sentiment

AI-GeneratedAs of July 1, 2026, **TEVA market sentiment** reflects a moderately bullish setup. The IV rank of 27.5\% sits in the lower quartile, signaling low volatility expectations and investor complacency—typically supportive of continuation moves. The put-call ratio of 0.1310 is notably bullish, indicating that call buyers outnumber put buyers by nearly 8-to-1, a strong bet on upside. The mean analyst target price of $40.90 implies meaningful upside from recent levels, suggesting the research community leans constructive on the TEVA price outlook. This confluence—muted IV, call dominance, and forward-looking price targets—reinforces a near-term bullish bias. Watch for a shift in IV rank above 40\% or a put-call ratio compression toward 0.25 as early warnings that sentiment is fading; current complacency may also create vulnerability if unexpected headlines emerge.
Analyst Rating
40.9000
Options Put/Call Ratio
12.1700%
Implied Volatility (IV)
27.8992

Market Structure

AI-GeneratedAs of July 1, 2026, **TEVA market structure** reveals a balanced chip distribution favoring longs. Institutional investors hold 62.34\% of shares outstanding, providing a significant layer of long-term support and reducing the risk of sudden liquidation pressure. The short interest ratio sits at just 2.88\% of float—well below sector averages—meaning bears have minimal leverage and downside catalysts face structural headwinds. Float size of 1.08 billion shares is substantial, yet institutional concentration underscores quality ownership. This **TEVA stock outlook** benefits from the absence of crowded bearish positioning; buybacks, index inclusion, or positive earnings surprises would find receptive hands. The structural foundation favors accumulation over distribution. Monitor institutional holdings for any notable shifts \(buy-ins or rebalancing\) and watch short interest for spikes above 4\% as a signal of building bearish conviction; current positioning remains squarely pro-long.
Float Shares
1083149969.0000
Short % of Float
0.0288
Institutional Holding
0.6233

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

Learn More About TEVA (Teva Pharmaceutical-Sp)

Blogs

›

TEVA: ZK Stack and AI help create an interesting and fair game ecosystem

FAQ

What data is used to generate the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

TEVA(Teva Pharmaceutical-Sp) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

How are technical indicators used in the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

What role does market sentiment play in the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

What common factors can influence the TEVA(Teva Pharmaceutical-Sp) price prediction?

x

How can price predictions be used to assess the current market state of TEVA(Teva Pharmaceutical-Sp)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.